담배 해로움 줄이기의 역사와 근거

키워드

참고문헌 (57)

1. Edwards R, "The problem of tobacco smoking", 328(7433), pp.217~219 (2004)
2. 한국보건사회연구원, "우리나라 국민의 건강결정요인 분석 2006", pp.18~19 (2006)
3. 보건복지부, "국민건강영양조사: 성인보건의식행태", pp.54~ (2006)
4. McNeill A, "Harm reduction", 328(7444), pp.885~887 (2004)
5. "Clearing the smoke: assessing the science base for tobacco harm reduction", National Academy Press
6. Foulds J, "Effect of smokeless tobacco (snus) on smoking and public health in Sweden", 12(4), pp.349~359 (2003)
7. Doll R, "Smoking and carcinoma of the lung", pp.739~48
8. Wynder EL, "Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma a study of 684 proved cases", pp.329~36
9. Wynder EL, "Experimental production of carcinoma with cigarette tar Tests with different mouse strains", pp.855~64
10. Wynder EL, "A study of tobacco carcinogenesis", pp.1193~200
11. US Department of Health and Human Services, "The health consequences of smoking: a report of the Surgeon General. Atlanta, GA, USA: Department of Health and Human Services, Centers for Disease Control and Prevention, National Centre for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health" (2004), Washington, DC, USA
12. Hoffmann D, "The changing cigarette", 26(4), pp.427~434 (1997)
13. Tindle HA, "Cessation Among Smokers of ＂Light＂ Cigarettes: results from the 2000 national health interview survey", 96, pp.1498~1504 (2006)
14. Shiffman S, "Smoker and ex-smoker reactions to cigarettes claiming reduced risk", 13(1), pp.78~84 (2004)
15. Stratton K, "Clearing the smoke: the science base for tobacco harm reduction--executive summary", 10(2), pp.189~195 (2001)
16. Martinet Y, "Would alternate tobacco products use be better than smoking?", 53(1), pp.1~4 (2006)
17. Wayne GF, "Potential reduced exposure products (PREPs) in industry trial testimony", 15, pp.iv90~iv97 (2006)
18. Godtfredsen NS, "Smoking reduction, smoking cessation, and mortality: a 16- year follow-up of 19,732 men and women from The Copenhagen Centre for Prospective Population Studies", 156, pp.994~1001 (2002)
19. Godtfredsen NS, "Risk of hospital admission for COPD following smoking cessation and reduction: a Danish population study", 57, pp.967~972 (2002)
20. Godtfredsen NS, "Smoking reduction, smoking cessation, and incidence of fatal and non-fatal myocardial infarction in Denmark 1976-1998: a pooled cohort study", 57, pp.412~416 (2003)
21. GodtfredsenNS, "Effect of Smoking Reduction on Lung Cancer Risk", 294, pp.1505~1510 (2005)
22. Kozlowski LT, "Applying the risk", use equilibrium: use medicinal nicotine now for harm reduction, 2001, pp.10(3), 201~203
23. Rodu B, "Nicotine maintenance for inveterate smokers", 6, pp.17~21 (1999)
24. Hoffmann D, "The changing cigarette, 1950- 1995", 50(4), pp.307~364 (1997)
25. Wynder EL, "The effect of low-yield cigarette smoking on lung cancer risk", pp.1223~30
26. Lee PN, "Lung cancer and type of cigarette smoked", 13(11), pp.951~976 (2001)
27. Lee PN, "Mortality and type of cigarette smoked", pp.16~22
28. Lubin JH, "Patterns of lung cancer risk according to type of cigarette smoked", berri(f), pp.569~76
29. Doll R, "Mortality in relation to smoking 40 years' observations on male British doctors", pp.901~11
30. Thun MJ, "Health impact of ＂reduced yield＂ cigarettes: a critical assessment of the epidemiological evidence", 10, pp.4~11 (2001)
31. Stellman SD, "Risk of squamous cell carcinoma and adenocarcinoma of the lung in relation to lifetime filter cigarette smoking", 80, pp.382~388 (1997)
32. Marugame T, "Filter cigarette smoking and lung cancer risk; a hospital-based case--control study in Japan", 90, pp.646~651 (2004)
33. Brooks DR, "Influence of type of cigarette on peripheral versus central lung cancer", 14(3), pp.576~581 (2005)
34. Peeler CE, "Cigarette testing and the Federal Trade Commission: a historical overview. The FTC cigarette test method for determining tar, nicotine, and carbon monoxide yields of US cigarettes: report of the NCI Expert Committee", (96-4028) (1996), Bethesda, Maryland: National Institutes of Health
35. Harris JE, "Cigarette tar yields in relation to mortality from lung cancer in the cancer prevention study II prospective cohort, 1982-8", 328(7431), pp.72~ (2004)
36. Warner KE, "Will the next generation of ＂safer＂ cigarettes be safer?", 27(10), pp.543~550 (2005)
37. Kozlowski LT, "Applying the risk", use equilibrium: use medicinal nicotine now for harm reduction, 2001, pp.10(3), 201~203
38. Murray RP, "Safety of nicotine polacrilex gum used by 3,094 participants in the Lung Health Study", 109(2), pp.438~445 (1996)
39. SladeJ, "Eclipse: does it live up to its health claims?", 11, pp.ii64~ii70 (2002)
40. LeeEM, "Quantitative comparisons between a nicotine delivery device (Eclipse) and conventional cigarette smoking", 6(1), pp.95~102 (2004)
41. HughesJ, "The effect of a novel smoking system＂Accord＂ on ongoing smoking and toxin exposure", 6(6), pp.1021~1027 (2004)
42. Hughes JR, "Smoking behaviour and toxin exposure during six weeks use of a potential reduced exposure product: Omni", 13(2), pp.175~179 (2004)
43. CDC, "Fact Sheet: Smokeless (Oral) tobacco" (2007)
44. Vainio H, "Smokeless tobacco: harm reduction or nicotine overload?", 12(2), pp.89~92 (2003)
45. Rosn M, "Attack rate, mortality and case fatality for acute myocardial infarction in Sweden during 198795. Results from the National AMI register in Sweden", 248(2), pp.159~164 (2000)
46. Daniel Roth H, "Health risks of smoking compared to Swedish snus", 17(13), pp.741~748 (2005)
47. RoduB, "Tobacco harm reduction: an alternative cessation strategy for inveterate smokers", 3, pp.37~ (2006)
48. Henley SJ, "Tobacco-related disease mortality among men who switched from cigarettes to spit tobacco", 16(1), pp.22~28 (2007)
49. Luo J, "Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study", 369(9578), pp.2015~2020 (2007)
50. Gartner CE, "Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study", 369(9578), pp.2010~2014 (2007)
51. Lee PN, "Circulatory disease and smokeless tobacco in Western populations: a review of the evidence", 25 (2007)
52. Bates C, "European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health", 12(4), pp.360~367 (2003)
53. Ramstrm LM, "Role of snus in initiation and cessation of tobacco smoking in Sweden", 15(3), pp.210~214 (2006)
54. Gray N, "Toward a comprehensive long term nicotine policy", 14(3), pp.161~165 (2005)
55. NIH State-of-the-Science Conference Statement on Tobacco Use: prevention, cessation, and control, "NIH Consens State Sci Statements", 23(3), pp.1~26 (2006)
56. Bates C, "European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health", 12(4), pp.360~367 (2003)
57. Savitz DA, "Public health implications of smokeless tobacco use as a harm reduction strategy", 96(11), pp.1934~1939 (2006)

관련 논문AI추천